Adverse events 2.0—Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology

Lucie Heinzerling, Paolo A. Ascierto, Reinhard Dummer, Helen Gogas, Jean Jacques Grob, Celeste Lebbe, Georgina V. Long, Grant McArthur, Javid J. Moslehi, Tomas G. Neilan, Antoni Ribas, Caroline Robert, Dirk Schadendorf, Jedd D. Wolchok, Axel Hauschild

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)29-31
Number of pages3
JournalEuropean Journal of Cancer
Volume112
DOIs
Publication statusPublished - May 1 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Heinzerling, L., Ascierto, P. A., Dummer, R., Gogas, H., Grob, J. J., Lebbe, C., Long, G. V., McArthur, G., Moslehi, J. J., Neilan, T. G., Ribas, A., Robert, C., Schadendorf, D., Wolchok, J. D., & Hauschild, A. (2019). Adverse events 2.0—Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology. European Journal of Cancer, 112, 29-31. https://doi.org/10.1016/j.ejca.2019.01.015